Chemistry Analyzer Piccolo Xpress, CLIA Waived (AMBIS 2247161)
ID: RFQ-NIAID-25-2247161Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/5b6e87ff96cb4f499cb987ea2e64d6b0/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Piccolo Xpress Chemistry Analyzers, essential for ongoing clinical trials in Kenya. The analyzers must be brand-name Piccolo Xpress models to ensure compatibility and continuity with existing laboratory equipment, as they are critical for accurate and reliable diagnostic testing in the Vaccine Research Center's post-discharge study. This procurement reflects the NIH's commitment to enhancing clinical diagnostics capabilities through efficient and portable testing solutions. Interested vendors must submit their quotes by January 13, 2025, at 4:00 PM EST, and can direct inquiries to Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.

    Files
    Title
    Posted
    RFQ-NIAID-25-2247161_Specifications.pdf
    The document outlines the specifications for a Request for Quotation (RFQ) issued by the National Institute of Allergy and Infectious Diseases (NIAID) for a portable, fully automated clinical chemistry analyzer. The instrument must provide rapid diagnostic results with minimal user interaction and be capable of performing over 30 blood chemistry tests from more than 14 test panels. It is vital that the analyzer be compatible with existing laboratory supplies and match a previously used instrument to ensure data consistency. The specified product is the Piccolo® Xpress™ Analyzer, which provides quick results (12 minutes) using single-use reagent discs and has features such as an onboard quality control system, touchscreen display, and built-in thermal printer. The analyzer supports various sample types (whole blood, serum, plasma) and features memory for up to 5000 results. This RFQ emphasizes the government’s focus on obtaining efficient diagnostic tools for on-site testing, reflecting a continued investment in health technology to enhance clinical diagnostics capabilities.
    Terms and Conditions_FAR 52.212-5_Nov 2024.pdf
    Lifecycle
    Title
    Type
    Chemistry Analyzer Piccolo Xpress, CLIA Waived (AMBIS 2247161)
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    Piccolo Chemistry Analyzer - Warm Springs Service Unit
    Active
    Health And Human Services, Department Of
    The Indian Health Service, part of the Department of Health and Human Services, is seeking proposals for the supply and delivery of two Piccolo Express analyzers for the Warm Springs Service Unit in Oregon. The procurement includes a firm fixed price purchase order that encompasses a five-year warranty and CLIA waived panels for various medical tests, including comprehensive metabolic and lipid panels. These analyzers are crucial for providing rapid and accurate point-of-care testing, enhancing the healthcare services at the Warm Springs Health and Wellness Center. Interested vendors must submit their quotations, including a catalog demonstrating compliance with specifications, to PORAOAcquisition@ihs.gov by the specified deadline, with a required delivery date of 60 days from the award.
    Inverted Routine Microscope System and Prime Life Science sCMOS Camera
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured Inverted Routine Microscope Systems and Prime Life Science sCMOS Cameras. This Sources Sought notice aims to gather details regarding the availability and capability of U.S. manufactured products that meet specific technical specifications, including advanced imaging capabilities and various illumination options. The procurement is crucial for supporting the NIH's oversight of foreign grant recipients and enhancing their administrative operations. Interested vendors must submit their capability statements by 11:59 AM Eastern Time on January 10, 2025, to the NIAID electronic Simplified Acquisition Submission System (eSASS), with all submissions being treated confidentially. For further inquiries, vendors can contact Rubyanne Matthews at rubyanne.matthews@nih.gov.
    NHANES General Chemistry Laboratory Testing 2025-2030
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the NHANES General Chemistry Laboratory Testing contract for the period from February 14, 2025, to February 13, 2030. The objective is to obtain Clinical Laboratory Improvement Amendments (CLIA) certified laboratory measurements on biological specimens to support the National Health and Nutrition Examination Survey (NHANES), which aims to provide national statistics on the health and nutritional status of the U.S. population. This initiative is critical for generating national estimates and monitoring trends in chronic diseases, with an expected examination of approximately 20,000 individuals during the contract term. Interested contractors must submit their proposals electronically by January 9, 2025, and can direct inquiries to David Santimaw at zgm2@cdc.gov or Arianna Williams at xsm2@cdc.gov.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a comprehensive quality assurance program for virologic assays related to HIV and other viral pathogens. The objective is to ensure the validity and comparability of laboratory data through proficiency testing panels and real-time assay controls, which are critical for ongoing and future studies on infectious diseases. This program has been operational since 1988 and supports approximately 110 laboratories globally, emphasizing the importance of maintaining high standards in virologic testing. Proposals are expected to be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the solicitation anticipated to be available on or about January 9, 2025. For further inquiries, interested parties can contact Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov.
    Gore Medical branded stents (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.